WHO ICTRP trial
Study of Acute myelogenic Leukemia (AML) treatment for patients who can not…
EUCTR2020-005461-14-NO · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-005461-14-NO |
|---|---|
| Public title | Study of Acute myelogenic Leukemia (AML) treatment for patients who can not recieve intensiv chemotherapy combining standard treatment (Azacitidin ) with study medicine(low dose Venetoclax) for better responce and we will look at effect of medicines on leukemic cells and possible resistence developement to help find new ways for treatment |
| Scientific title | The Nordic AML Group – LD-VenEx: PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (INCLUDING EXPLORATORY EVALUATION OF EX VIVO DRUG SENSITIVITY AND RESISTANCE SCREENING) - NAMLG-001 LD-VenX |
| Primary sponsor | Righospitalet |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Denmark;Norway |
| Conditions | Acute Myelogenic Leukemia is aggressiv leukemia and treatment i challenging specialy in patients not eligible for intensiv chemotherapy or relapsed after intensiv chemotherapy.In this study we will use study medicine (low dose Venetoclax)in… |
| Interventions | Trade Name: Venclyxto Product Name: VENETOCLAX Pharmaceutical Form: Tablet INN or Proposed INN: VENETOCLAX Other descriptive name: Venetoclax Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 400- |
| Registration date | Dec 5, 2021 |
| Target size | 117 |
| Secondary IDs | LD-VenEx |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: